EUVIMEDEUVIMED entdecken
Crossref

Prediction of cervical cancer precursor lesions by quantitative methylation specific PCR : A retrospective study

Moody Al Roomy, Wassim Chehadeh iD, Rana Al Awadhi iD

Cytopathology · 2023-05 · 34 (3) · 204-210

DOI: 10.1111/cyt.13213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytopathology, online erschienen am 16.02.2023. Verfasst von Moody Al Roomy und 2 weiteren Autor:innen. Beteiligte Einrichtung: College of Graduate Studies, Kuwait University, Khaldiya, Kuwait. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Uterine Cervical Dysplasia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 23 Literaturangaben. Gefördert von: Kuwait University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This study was undertaken to evaluate the performance of FAM19A4 and hsa‐mir‐124‐2 hypermethylation as a triage tool for women who are at risk of developing cervical cancer or high‐grade cervical cancer precursor lesions by taking into consideration the cytology report, histology diagnosis, and human papillomavirus (HPV) status.

Methods

A total of 330 cervical ThinPrep samples were retrospectively collected and used for DNA isolation. HPV DNA was detected by real‐time polymerase chain reaction (PCR), and HPV genotypes were identified by Sanger‐based sequencing. DNA extracts were bisulphite‐treated, and hypermethylation of FAM19A4 and hsa‐mir‐124‐2 genes was detected by a quantitative methylation‐specific PCR (qMSP) test using the QIAsure Methylation assay.

Results

Hypermethylated genes were detected in 27 (9.6%) cervical samples, mostly found in women diagnosed with high‐grade squamous intraepithelial legions (77.8%) or cervical intraepithelial neoplasia grade 3 (CIN3) (72.7%). The sensitivity and the specificity of the qMSP test for predicting CIN3 lesions among women with high‐risk HPV was 75% and 91%, respectively. Discussion/Conclusion There was a significant correlation between high‐grade cervical cancer precursor lesions and detection of hypermethylated genes in samples positive for high‐risk HPV. Our results suggest that the QIAsure Methylation test can be used as a triage tool to identify women at risk for cervical cancer progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsUterine Cervical DysplasiaHumansFemaleRetrospective StudiesDNA MethylationPolymerase Chain ReactionPapillomaviridaeEarly Detection of Cancer

Stichwörter der Autor:innen

HPVQIAsure methylation testcervical sampleshigh-grade cervical cancer lesions

Autor:innen und Institutionen

  • College of Graduate Studies, Kuwait University, Khaldiya, Kuwait.
  • Virology Unit, Department of Microbiology, Faculty of Medicine, Kuwait University, Jabriya, Kuwait.
  • Department of Medical Laboratory Sciences, Faculty of Allied Health Sciences, Kuwait University, Jabriya, Kuwait.

ORCID-Profile: Wassim Chehadeh, Rana Al Awadhi

Förderung

  • Kuwait University

Zitieren

APA

Al Roomy, M., Chehadeh, W., & Al Awadhi, R. (2023). Prediction of cervical cancer precursor lesions by quantitative methylation specific PCR : A retrospective study. Cytopathology, 34(3), 204-210. https://doi.org/10.1111/cyt.13213

Vancouver

Al Roomy M, Chehadeh W, Al Awadhi R. Prediction of cervical cancer precursor lesions by quantitative methylation specific PCR : A retrospective study. Cytopathology. 2023;34(3):204-210. doi:10.1111/cyt.13213

BibTeX
@article{AlRoomy2023,
  author = {Al Roomy, Moody and Chehadeh, Wassim and Al Awadhi, Rana},
  title = {Prediction of cervical cancer precursor lesions by quantitative methylation specific PCR : A retrospective study},
  journal = {Cytopathology},
  year = {2023},
  volume = {34},
  number = {3},
  pages = {204--210},
  doi = {10.1111/cyt.13213}
}
Kostenlos starten →